119 related articles for article (PubMed ID: 10653376)
1. An association between cytomegalovirus infection and chronic rejection after liver transplantation.
Evans PC; Soin A; Wreghitt TG; Taylor CJ; Wight DG; Alexander GJ
Transplantation; 2000 Jan; 69(1):30-5. PubMed ID: 10653376
[TBL] [Abstract][Full Text] [Related]
2. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts.
Evans PC; Smith S; Hirschfield G; Rigopoulou E; Wreghitt TG; Wight DG; Taylor CJ; Alexander GJ
J Hepatol; 2001 May; 34(5):711-5. PubMed ID: 11434617
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts.
Evans PC; Coleman N; Wreghitt TG; Wight DG; Alexander GJ
J Hepatol; 1999 Nov; 31(5):913-20. PubMed ID: 10580590
[TBL] [Abstract][Full Text] [Related]
4. Sex mismatch as a risk factor for chronic rejection of liver allografts.
Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
[TBL] [Abstract][Full Text] [Related]
5. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
6. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
Rosen HR; Corless CL; Rabkin J; Chou S
Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients.
Sarcinella L; Mazzulli T; Willey B; Humar A
J Clin Virol; 2002 Feb; 24(1-2):99-105. PubMed ID: 11744434
[TBL] [Abstract][Full Text] [Related]
8. Persistent cytomegalovirus in liver allografts with chronic rejection.
Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
[TBL] [Abstract][Full Text] [Related]
9. Detection of human leukocyte antigen compatibility and antibodies in liver transplantation in China.
Meng XQ; Zhang X; Fan J; Zhou L; Hao B; Chen XM; Ma WH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):141-5. PubMed ID: 19357026
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection and graft rejection in renal transplantation.
Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
[TBL] [Abstract][Full Text] [Related]
12. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation.
Sampaio AM; Guardia AC; Milan A; Sasaki AN; Andrade PD; Bonon SH; Stucchi RS; Botelho Costa SC; Boin IF
Transplant Proc; 2012 Oct; 44(8):2455-8. PubMed ID: 23026619
[TBL] [Abstract][Full Text] [Related]
13. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
14. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients.
Humar A; Gillingham KJ; Payne WD; Dunn DL; Sutherland DE; Matas AJ
Transplantation; 1999 Dec; 68(12):1879-83. PubMed ID: 10628768
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
16. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
[TBL] [Abstract][Full Text] [Related]
18. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
20. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
